137 results
Page 4 of 7
8-K
EX-1.1
v40ah3ng2yt1o9ehsbl
17 Jul 20
Entry into a Material Definitive Agreement
5:19pm
424B5
9xfg5ke2 ly0l4dja6ih
17 Jul 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.1
eeu7r lc5k2xta
16 Jun 20
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
7:32am
8-K
EX-99.1
m05j2r ns
2 Apr 20
Moleculin Announces Additional Positive Safety Data in EU AML Trial
7:30am
8-K
EX-99.1
ved3zz1ec
16 Mar 20
Regulation FD Disclosure
12:00am
424B5
3s84fmcfdd
6 Feb 20
Prospectus supplement for primary offering
5:08pm
8-K
EX-4.1
a7d 3rcz14tozx
6 Feb 20
Entry into a Material Definitive Agreement
9:06am
8-K
EX-4.2
ps73ibi5d
6 Feb 20
Entry into a Material Definitive Agreement
9:06am
8-K
EX-1.1
tqxfz4mr2ft3lwq
6 Feb 20
Entry into a Material Definitive Agreement
9:06am
8-K
EX-99.1
f4aee
5 Feb 20
Moleculin to Seek Accelerated FDA Approval and Plans for Pivotal Phase 2 AML Trial
7:30am
8-K
EX-99.1
qrvg nmzh
3 Feb 20
Moleculin Announces Successful Completion of US Phase 1 AML Trial of Annamycin
7:32am
8-K
EX-99.1
xqno8q8h7gukjdi5
13 Jan 20
Regulation FD Disclosure
7:01am